Delivery Order SPE2DB22D3501-SPE2DB24FWH99

Award Date 7/19/24
Potential Completion Date 8/9/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 delivery order contract is for the supply of DARZALEX FASPRO, a 1,800mg/30,000 15ml specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of November 14, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $22,081.68 firm fixed-price delivery order is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract has a completion date of September 25, 2024. AmerisourceBergen holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
This federal contract award is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $57,112.20 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024. The contract is a firm fixed-price Delivery Order with a completion date of January 10, 2025. This award is likely part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $11,040.84 delivery order is for DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract has a firm fixed-price pricing type and a completion date of September 24, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been awarded this contract without any set-aside...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $17,940.63, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at $999,999,999 and runs through November 2026. The contract provides for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product,...
This federal contract award is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA). The $34,267.32 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $80,516.55, is for the delivery of DARZALEX FASPRO 1,800mg-30,000 15ml, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 13, 2023. This award does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,881.20 firm fixed-price delivery order is for DARZALEX FASPR 1800 1S, a medical product, with a completion date of February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $33,122.52 Delivery Order is for the provision of 4,564,490,081 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a firm fixed price, with a completion date of May 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $17,940.63 and is a delivery order with a firm fixed price pricing type. The ultimate completion date is April 7, 2025. The contract is for the delivery of DARZALEX FASPRO, a 1,800mg-30,000 15ml pharmaceutical product, to support military treatment facilities, veterans' healthcare...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWH99
    Delivery Order

This federal contract award, valued at $11,040.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the delivery of 4,565,214,050 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. This delivery order contract has a firm fixed price pricing type and an ultimate completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide a wide range of essential medical commodities, including prescription drugs, vaccines, and medical supplies, to support military treatment facilities, veterans' hospitals, and other government healthcare programs. This particular award does not utilize any set-aside designation.

Generated 10/18/24, 9:02 AM